Literature DB >> 3799744

Anticardiolipin antibodies and complement in ninety-nine women with habitual abortion.

A M Unander, R Norberg, L Hahn, L Arfors.   

Abstract

Immunologic investigations were performed on sera from 99 women with habitual abortion (three or more consecutive miscarriages). All were considered healthy and clinical investigations had not revealed any cause for the miscarriages. Sixty-eight were considered to have primary habitual abortion whereas 31 had secondary habitual abortion. Increased anticardiolipin antibody levels were found in 42 patients. None had a primary diagnosis of systemic lupus erythematosus, but at follow-up studies one of them fulfilled the diagnostic criteria of systemic lupus erythematosus. Ten sera, all from patients with primary habitual abortion, showed high anticardiolipin antibody values (greater than or equal to 10 units) concomitant with significantly lower levels of complement factor C4 than those found in sera with moderate or normal anticardiolipin antibody levels. There was no indication of genetic defects explaining the low C4 values, which could be explained at least in part by an activation of complement by the classical pathway.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3799744     DOI: 10.1016/0002-9378(87)90218-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

Review 1.  Pregnancy and antibodies to phospholipids.

Authors:  M J Walport
Journal:  Ann Rheum Dis       Date:  1989-10       Impact factor: 19.103

Review 2.  Anticardiolipin antibody.

Authors:  G R Hughes; M A Khamashta
Journal:  BMJ       Date:  1989-12-09

3.  Antiphospholipid syndrome.

Authors:  M Khamashta; G R Hughes
Journal:  BMJ       Date:  1993-10-09

4.  Risk factors in the pregnancy of patients with systemic lupus erythematosus: association of hypocomplementaemia with poor prognosis.

Authors:  S Shibata; T Sasaki; Y Hirabayashi; J Seino; K Okamura; K Yoshinaga; N Morito; R Kasukawa; S Aotuka; R Yokohari
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

Review 5.  The 'antiphospholipid syndrome' and the 'lupus anticoagulant'.

Authors:  J S Cameron; G Frampton
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

Review 6.  The role of IVIG in the management of patients with antiphospholipid antibodies and recurrent pregnancy losses.

Authors:  A Parke
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

7.  Prevalence of antiphospholipid antibodies in patients with fetal loss.

Authors:  H J Out; H W Bruinse; G C Christiaens; M van Vliet; J F Meilof; P G de Groot; R J Smeenk; R H Derksen
Journal:  Ann Rheum Dis       Date:  1991-08       Impact factor: 19.103

8.  Anti-cardiolipin antibodies in ischaemic heart disease.

Authors:  P Klemp; R C Cooper; F J Strauss; E R Jordaan; J Z Przybojewski; N Nel
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

Review 9.  Role of complement in antiphospholipid antibody-mediated thrombosis.

Authors:  Kathleen M O'Neil
Journal:  Curr Rheumatol Rep       Date:  2007-06       Impact factor: 4.686

10.  Recurrent fetal loss and antiphospholipid antibodies: clinical and therapeutic aspects.

Authors:  O Blétry; A M Piette
Journal:  Infect Dis Obstet Gynecol       Date:  1997
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.